Abstract | BACKGROUND: CASE PRESENTATION: CONCLUSIONS: We here present a severe case of acquired immunodeficiency with anti-IFNγ autoantibodies with simultaneous, disseminated infections with both viral and microbial pathogens. The case illustrates how the diagnosis can cause considerable difficulties and is often delayed due to unusual presentations. Histological studies in our patient give further insight into the pathophysiological significance of impaired IFNγ signalling. B-cell-depleting therapy with rituximab offers a targeted treatment approach in AIIA.
|
Authors | Malte Roerden, Rainer Döffinger, Gabriela Barcenas-Morales, Stephan Forchhammer, Stefanie Döbele, Christoph P Berg |
Journal | BMC infectious diseases
(BMC Infect Dis)
Vol. 20
Issue 1
Pg. 828
(Nov 11 2020)
ISSN: 1471-2334 [Electronic] England |
PMID | 33176707
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Antiviral Agents
- Autoantibodies
- IFNG protein, human
- Immunologic Factors
- Interleukin-12
- Interferon-gamma
|
Topics |
- Adult
- Anti-Bacterial Agents
(therapeutic use)
- Antiviral Agents
(therapeutic use)
- Autoantibodies
(blood, immunology)
- Biopsy
- Cytomegalovirus
(isolation & purification)
- Cytomegalovirus Infections
(complications, diagnosis, drug therapy, virology)
- Delayed Diagnosis
- Female
- Follow-Up Studies
- Humans
- Immunologic Deficiency Syndromes
(complications, diagnosis, drug therapy)
- Immunologic Factors
(therapeutic use)
- Interferon-gamma
(immunology, metabolism)
- Interleukin-12
(metabolism)
- Lymphadenopathy
(complications, diagnosis, drug therapy, pathology)
- Mycobacterium avium Complex
(isolation & purification)
- Mycobacterium avium-intracellulare Infection
(complications, diagnosis, drug therapy, microbiology)
- Salmonella Infections
(complications, diagnosis, drug therapy, microbiology)
- Salmonella typhimurium
(isolation & purification)
- Treatment Outcome
|